NCT02006706View on ClinicalTrials.gov

A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 10, 2006

Primary Completion Date

November 23, 2007

Study Completion Date

November 23, 2007

Conditions
Rheumatoid Arthritis
Interventions
DRUG

rituximab [MabThera/Rituxan]

1000 mg iv Days 1 and 15

DRUG

methotrexate

10 - 25 mg/week

DRUG

methylprednisolone

iv administration on Day 1 and 15 prior to MabThera/Rituxan infusion

Trial Locations (3)

11000

Belgrade

18250

Niška Banja

21000

Nova Sad

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02006706 - A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy | Biotech Hunter | Biotech Hunter